Fed agency turns to Regeneron for first drugs against MERS

By John Golden

No Comment

Regeneron lab scientists have identified two antibodies to potentially prevent and treat highly fatal Middle East Respiratory Syndrome.

This content is for Westfair Online members only. Please login to view this content. Become a member by Registering Here. If you would prefer to start with a 12 week free trial, Click Here.

Print

About the author

John Golden
As managing editor of the Business Journals, John Golden directs news coverage of Westchester and Fairfield counties and the Hudson Valley region. He was an award-winning upstate columnist and feature writer before joining the Business Journal in 2007. He is the author of “Northern Drift: Sketches on the New York Frontier,” a collection of his regional journalism.

Related Articles

VIDEOS